Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00242827
Status:
TERMINATED
Last Update Posted:
2012-08-23
First Post:
2005-09-27
Brief Title:
Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma
Sponsor:
Cephalon
Organization:
Teva Branded Pharmaceutical Products RD Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-04
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2007-05
Completion Date Type:
None
First Submit Date:
2005-09-27
First Submit QC Date:
October 20 2005
Study First Post Date:
2005-10-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-08-22
Last Update Post Date:
2012-08-23
Last Update Post Date Type:
ESTIMATED